Search

Search bills, members, committees and pages...

SB 968

Missouri SenateIntroduced

Summary

SB 968, which modifies provisions relating to pharmacy benefits managers, was introduced in the Senate on Dec 1, 2025 by Sen. Travis Fitzwater (R). It last saw action on Mar 12, 2026: Bill Combined w/SCS SBs 984 & 968.


Record

Text

SB 968 has no co-sponsors and has not gone to a roll call.

sb968/introduced.txt
SECOND REGULAR SESSION
SENATE BILL NO. 968
103RD GENERAL ASSEMBLY
INTRODUCED BY SENATOR FITZWATER.
5510S.01I KRISTINA MARTIN, Secretary
AN ACT
To repeal sections 338.015 and 376.388, RSMo, and to enact in lieu thereof two new sections
relating to pharmacy benefit managers.
Be it enacted by the General Assembly of the State of Missouri, as follows:
Section A. Sections 338.015 and 376.388, RSMo, are
repealed and two new sections enacted in lieu thereof, to be
known as sections 338.015 and 376.388, to read as follows:
338.015. 1. The provisions of sections 338.010 to
338.015 shall not be construed to inhibit the patient's
freedom of choice to obtain prescription services from any
licensed pharmacist. However, nothing in sections 338.010
to 338.315 abrogates the patient's ability to waive freedom
of choice under any contract with regard to payment or
coverage of prescription expense.
2. All pharmacists may provide pharmaceutical
consultation and advice to persons concerning the safe and
therapeutic use of their prescription drugs.
3. All patients shall have the right to receive a
written prescription from their prescriber to take to the
facility of their choice or to have an electronic
prescription transmitted to the facility of their choice.
4. Notwithstanding any other provision of law to the
contrary, no pharmacy benefits manager shall:
EXPLANATION-Matter enclosed in bold-faced brackets [thus] in this bill is not enacted
and is intended to be omitted in the law.
SB 968 2
(1) Prohibit or limit a covered person from selecting
a pharmacy or pharmacist of their choice or impose a
monetary advantage or penalty that would affect a covered
person's choice if a pharmacy or pharmacist has agreed to
participate in a covered person's health benefit plan. A
monetary advantage or penalty includes, but is not limited
to, a copayment or coinsurance variation, a reduction in
reimbursement for services, a promotion of one participating
pharmacy over another, or comparing the reimbursement rates
of a pharmacy against mail order pharmacy reimbursement
rates;
(2) Impose upon a pharmacy or pharmacist any course of
study, accreditation, certification, or credentialing as a
condition of participation that is inconsistent with, more
stringent than, or in addition to any state law or rules
promulgated by the board of pharmacy for the purpose of
licensure or certification;
(3) Pay or reimburse a pharmacy or pharmacist in this
state for an amount less than the most recently published
National Average Drug Acquisition Cost for a prescription
drug on the date that the prescription drug is administered
or dispensed.
376.388. 1. As used in this section, unless the
context requires otherwise, the following terms shall mean:
(1) "Contracted pharmacy" or "pharmacy", a pharmacy
located in Missouri participating in the network of a
pharmacy benefits manager through a direct or indirect
contract;
(2) "Health carrier", an entity subject to the
insurance laws and regulations of this state that contracts
or offers to contract to provide, deliver, arrange for, pay
for, or reimburse any of the costs of health care services,
SB 968 3
including a sickness and accident insurance company, a
health maintenance organization, a nonprofit hospital and
health service corporation, or any other entity providing a
plan of health insurance, health benefits, or health
services, except that such plan shall not include any
coverage pursuant to a liability insurance policy, workers'
compensation insurance policy, or medical payments insurance
issued as a supplement to a liability policy;
(3) "Maximum allowable cost", [the per-unit amount
that a pharmacy benefits manager reimburses a pharmacist for
a prescription drug, excluding a dispensing or professional
fee] the maximum amount that a pharmacy benefits manager
shall reimburse a pharmacy for the cost of a multisourced
drug, medical product, or a device, not including the
dispensing fee for the drug;
(4) "Maximum allowable cost list" or "MAC list", [a
listing of drug products that meet the standard described in
this section] the multisource generic drugs, medical
products, and devices for which a maximum allowable cost has
been established by a pharmacy benefits manager or a
purchaser;
(5) "National Average Drug Acquisition Cost" or
"NADAC", the monthly survey of retail pharmacies conducted
by the federal Centers for Medicare and Medicaid Services to
determine the average acquisition cost for drugs;
(6) "Pharmacy", as such term is defined in chapter 338;
[(6)] (7) "Pharmacy benefits manager", [an entity that
contracts with pharmacies on behalf of health carriers or
any health plan sponsored by the state or a political
subdivision of the state] a person, business, or entity,
including a wholly or partially owned or controlled
subsidiary of a pharmacy benefits manager, that provides
SB 968 4
claims processing services or other drug or device services,
or both, for health benefit plans or health carriers. A
"pharmacy benefits manager" shall not include:
(a) A health care professional licensed to practice in
this state;
(b) A health care facility licensed in this state;
(c) A consultant who only provides advice as to the
selection or performance of a pharmacy benefits manager; or
(d) An entity that provides claims processing services
or other drug or device services, or both, exclusively for
its enrollees;
(8) "Pharmacy benefits manager affiliate":
(a) A pharmacy or pharmacist that directly or
indirectly, through one or more intermediaries, owns or
controls a pharmacy with a pharmacy benefits manager; or
(b) A pharmacy that directly or indirectly, through
one or more intermediaries, is owned or under common
ownership or control of a pharmacy benefits manager.
2. Upon each contract execution or renewal between a
pharmacy benefits manager and a pharmacy or between a
pharmacy benefits manager and a pharmacy's contracting
representative or agent, such as a pharmacy services
administrative organization, a pharmacy benefits manager
shall, with respect to such contract or renewal:
(1) Include in such contract or renewal the sources
utilized to determine maximum allowable cost and update such
pricing information at least every seven days; and
(2) Maintain a procedure to eliminate products from
the maximum allowable cost list of drugs subject to such
pricing or modify maximum allowable cost pricing at least
every seven days, if such drugs do not meet the standards
SB 968 5
and requirements of this section, in order to remain
consistent with pricing changes in the marketplace.
3. A pharmacy benefits manager shall reimburse
pharmacies for drugs subject to maximum allowable cost
pricing that has been updated to reflect market pricing at
least every seven days as set forth under subdivision (1) of
subsection 2 of this section. For each claim, the
reimbursement shall be the greater of the maximum allowable
cost pricing or the current NADAC pricing.
4. A pharmacy benefits manager shall not place a drug
on a maximum allowable cost list unless there are at least
two therapeutically equivalent multisource generic drugs, or
at least one generic drug available from at least one
manufacturer, generally available for purchase by network
pharmacies from national or regional wholesalers.
5. All contracts between a pharmacy benefits manager
and a contracted pharmacy or between a pharmacy benefits
manager and a pharmacy's contracting representative or
agent, such as a pharmacy services administrative
organization, shall include a process to internally appeal,
investigate, and resolve disputes regarding the NADAC and
maximum allowable cost pricing. The process shall include
the following:
(1) The right to appeal shall be limited to fourteen
calendar days following the reimbursement of the initial
claim; and
(2) A requirement that the pharmacy benefits manager
shall respond to an appeal described in this subsection no
later than fourteen calendar days after the date the appeal
was received by such pharmacy benefits manager.
SB 968 6
No pharmacy benefits manager shall retaliate against a
contracted pharmacy for exercising its right to appeal to
the pharmacy benefits manager.
6. For appeals that are denied, the pharmacy benefits
manager shall provide the reason for the denial and identify
the national drug code of a drug product that may be
purchased by contracted pharmacies at a price at or below
the maximum allowable cost and, when applicable, may be
substituted lawfully.
7. If the appeal is successful, the pharmacy benefits
manager shall:
(1) Adjust the maximum allowable cost price that is
the subject of the appeal effective on the day after the
date the appeal is decided;
(2) Apply the adjusted maximum allowable cost price to
all similarly situated pharmacies as determined by the
pharmacy benefits manager; and
(3) Allow the pharmacy that succeeded in the appeal to
reverse and rebill the pharmacy benefits claim giving rise
to the appeal.
8. Appeals shall be upheld if:
(1) The pharmacy being reimbursed for the drug subject
to the maximum allowable cost pricing in question was not
reimbursed as required under subsection 3 of this section;
[or]
(2) The drug subject to the maximum allowable cost
pricing in question does not meet the requirements set forth
under subsection 4 of this section; or
(3) The drug subject to maximum allowable cost pricing
was reimbursed at a rate lower than the NADAC.
9. A pharmacy benefits manager shall reimburse any
pharmacist or pharmacy located in this state for an amount
SB 968 7
equal to what the pharmacy benefits manager reimburses a
pharmacy benefits manager affiliate for dispensing the same
prescription drug.
10. In addition to the reimbursements determined by
maximum allowable cost and the NADAC, a pharmacy benefits
manager shall reimburse the pharmacy or pharmacist a
dispensing fee in an amount no less than ninety percent of
the MO HealthNet professional dispensing fee in effect on
the date of service.

Modifies provisions relating to pharmacy benefits managers

Sponsors

Sen. Travis Fitzwater (R) sponsors SB 968 alone.

Committees

SB 968 went before 1 committee: Families, Seniors and Health.

Families, Seniors and Health
Families, Seniors and Health
Referred to · Jan 8, 2026

History

SB 968 has taken 5 actions since Dec 1, 2025, the latest on Mar 12, 2026.

ChamberAction
Mar 12, 2026
Senate
Bill Combined w/SCS SBs 984 & 968
Jan 21, 2026
Senate
Hearing Conducted S Families, Seniors and Health Committee
Jan 8, 2026
Senate
Second Read and Referred S Families, Seniors and Health Committee
Jan 7, 2026
Senate
S First Read
Dec 1, 2025
Senate
Prefiled

Votes

SB 968 has not gone to a roll call.


Source: senate.mo.gov · legiscan.com